ID   ESYT2_HUMAN             Reviewed;         921 AA.
AC   A0FGR8; A4D229; Q69YJ2; Q6UKI4; Q6ZTU0; Q6ZVU1; Q9BQS0; Q9NW47;
AC   Q9ULJ2;
DT   20-FEB-2007, integrated into UniProtKB/Swiss-Prot.
DT   28-NOV-2006, sequence version 1.
DT   22-JUL-2015, entry version 88.
DE   RecName: Full=Extended synaptotagmin-2;
DE            Short=E-Syt2;
DE   AltName: Full=Chr2Syt;
GN   Name=ESYT2; Synonyms=FAM62B, KIAA1228;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, SUBCELLULAR
RP   LOCATION, CALCIUM-DEPENDENT LIPID-BINDING, AND TISSUE SPECIFICITY.
RX   PubMed=17360437; DOI=10.1073/pnas.0611725104;
RA   Min S.-W., Chang W.-P., Suedhof T.C.;
RT   "E-Syts, a family of membranous Ca2+-sensor proteins with multiple C2
RT   domains.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:3823-3828(2007).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RA   Shan Y.X., Yu L.;
RL   Submitted (AUG-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 4 AND 5), NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 511-921 (ISOFORMS 1/2), AND VARIANT
RP   GLY-638.
RC   TISSUE=Esophageal carcinoma, and Thymus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,
RA   Kwasnicka D., Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z.,
RA   Lu F., Zeesman S., Nowaczyk M.J., Teshima I., Chitayat D., Shuman C.,
RA   Weksberg R., Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J.,
RA   Rahman N., Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F.,
RA   Belloni E., Shaffer L.G., Pober B., Morton C.C., Gusella J.F.,
RA   Bruns G.A.P., Korf B.R., Quade B.J., Ligon A.H., Ferguson H.,
RA   Higgins A.W., Leach N.T., Herrick S.R., Lemyre E., Farra C.G.,
RA   Kim H.-G., Summers A.M., Gripp K.W., Roberts W., Szatmari P.,
RA   Winsor E.J.T., Grzeschik K.-H., Teebi A., Minassian B.A., Kere J.,
RA   Armengol L., Pujana M.A., Estivill X., Wilson M.D., Koop B.F.,
RA   Tosi S., Moore G.E., Boright A.P., Zlotorynski E., Kerem B.,
RA   Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W.,
RA   Mural R.J., Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 79-921 (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=10574462; DOI=10.1093/dnares/6.5.337;
RA   Nagase T., Ishikawa K., Kikuno R., Hirosawa M., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XV.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 6:337-345(1999).
RN   [6]
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 141-921.
RC   TISSUE=Melanoma;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 454-921 (ISOFORM 6).
RC   TISSUE=Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 747-904.
RC   TISSUE=Brain;
RX   PubMed=11543631; DOI=10.1006/geno.2001.6619;
RA   Craxton M.A.;
RT   "Genomic analysis of synaptotagmin genes.";
RL   Genomics 77:43-49(2001).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-743, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17924679; DOI=10.1021/pr070152u;
RA   Yu L.R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
RT   "Improved titanium dioxide enrichment of phosphopeptides from HeLa
RT   cells and high confident phosphopeptide identification by cross-
RT   validation of MS/MS and MS/MS/MS spectra.";
RL   J. Proteome Res. 6:4150-4162(2007).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-743; SER-758 AND
RP   SER-761, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-743; SER-755; SER-758
RP   AND SER-761, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-691; SER-739; SER-748;
RP   SER-755; SER-758 AND SER-761, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [15]
RP   INTERACTION WITH FGFR1 AND AP2B1, SUBCELLULAR LOCATION, AND FUNCTION.
RX   PubMed=20833364; DOI=10.1016/j.devcel.2010.08.007;
RA   Jean S., Mikryukov A., Tremblay M.G., Baril J., Guillou F.,
RA   Bellenfant S., Moss T.;
RT   "Extended-synaptotagmin-2 mediates FGF receptor endocytosis and ERK
RT   activation in vivo.";
RL   Dev. Cell 19:426-439(2010).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-743; SER-758 AND
RP   SER-761, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-758 AND SER-761, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [19]
RP   FUNCTION, SUBCELLULAR LOCATION, TOPOLOGY, LIPID-BINDING, DOMAIN,
RP   MUTAGENESIS OF 833-LYS--LYS-840, AND INTERACTION WITH ESYT1 AND ESYT3.
RX   PubMed=23791178; DOI=10.1016/j.cell.2013.05.026;
RA   Giordano F., Saheki Y., Idevall-Hagren O., Colombo S.F.,
RA   Pirruccello M., Milosevic I., Gracheva E.O., Bagriantsev S.N.,
RA   Borgese N., De Camilli P.;
RT   "PI(4,5)P(2)-dependent and Ca(2+)-regulated ER-PM interactions
RT   mediated by the extended synaptotagmins.";
RL   Cell 153:1494-1509(2013).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-693; THR-705 AND
RP   SER-761, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [21]
RP   STRUCTURE BY NMR OF 222-350.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the third C2 domain of KIAA1228 protein.";
RL   Submitted (OCT-2006) to the PDB data bank.
RN   [22]
RP   X-RAY CRYSTALLOGRAPHY (2.44 ANGSTROMS) OF 191-662 IN COMPLEX WITH
RP   PHOSPHATIDYLETHANOLAMINE, LIPID-BINDING, FUNCTION, DOMAIN, AND
RP   SUBUNIT.
RX   PubMed=24847877; DOI=10.1038/nature13269;
RA   Schauder C.M., Wu X., Saheki Y., Narayanaswamy P., Torta F.,
RA   Wenk M.R., De Camilli P., Reinisch K.M.;
RT   "Structure of a lipid-bound extended synaptotagmin indicates a role in
RT   lipid transfer.";
RL   Nature 510:552-555(2014).
RN   [23]
RP   X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS) OF 363-660 IN COMPLEX WITH
RP   CALCIUM, DOMAIN, CALCIUM BINDING, AND MUTAGENESIS OF ASP-401; ASP-413
RP   AND ASP-466.
RX   PubMed=24373768; DOI=10.1016/j.str.2013.11.011;
RA   Xu J., Bacaj T., Zhou A., Tomchick D.R., Sudhof T.C., Rizo J.;
RT   "Structure and Ca(2+)-binding properties of the tandem C(2) domains of
RT   E-Syt2.";
RL   Structure 22:269-280(2014).
CC   -!- FUNCTION: Tethers the endoplasmic reticulum to the cell membrane
CC       and promotes the formation of appositions between the endoplasmic
CC       reticulum and the cell membrane. Binds glycerophospholipids in a
CC       barrel-like domain and may play a role in cellular lipid
CC       transport. Plays a role in FGF signaling via its role in the rapid
CC       internalization of FGFR1 that has been activated by FGF1 binding;
CC       this occurs most likely via the AP-2 complex.
CC       {ECO:0000269|PubMed:17360437, ECO:0000269|PubMed:20833364,
CC       ECO:0000269|PubMed:23791178, ECO:0000269|PubMed:24847877}.
CC   -!- SUBUNIT: Homodimer. Interacts with ESYT1 and ESYT3. Interacts with
CC       FGFR1 that has been activated by FGF1 binding. Interacts with the
CC       AP-2 complex; identified in a complex with the AP-2 complex and
CC       FGFR1. {ECO:0000269|PubMed:20833364, ECO:0000269|PubMed:23791178,
CC       ECO:0000269|PubMed:24373768, ECO:0000269|PubMed:24847877}.
CC   -!- INTERACTION:
CC       Self; NbExp=3; IntAct=EBI-3184170, EBI-3184170;
CC       Q9BSJ8:ESYT1; NbExp=4; IntAct=EBI-3184170, EBI-355956;
CC       A0FGR9:ESYT3; NbExp=3; IntAct=EBI-3184170, EBI-8771391;
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Peripheral membrane protein.
CC       Endoplasmic reticulum membrane; Multi-pass membrane protein.
CC       Note=Detected at sites of contact between the endoplasmic
CC       reticulum membrane and the cell membrane. Recruited to the cell
CC       membrane via the third C2 domain.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=A0FGR8-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=A0FGR8-2; Sequence=VSP_023239;
CC         Note=No experimental confirmation available.;
CC       Name=4;
CC         IsoId=A0FGR8-4; Sequence=VSP_023238, VSP_023241, VSP_023242;
CC         Note=No experimental confirmation available.;
CC       Name=5;
CC         IsoId=A0FGR8-5; Sequence=VSP_023236, VSP_023240;
CC         Note=No experimental confirmation available.;
CC       Name=6;
CC         IsoId=A0FGR8-6; Sequence=VSP_038324;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Widely expressed with high level in
CC       cerebellum. {ECO:0000269|PubMed:17360437}.
CC   -!- DOMAIN: Anchored to the endoplasmic reticulum membrane by a
CC       transmembrane hairpin structure; both N-terminus and C-terminus
CC       are cytoplasmic. {ECO:0000269|PubMed:23791178}.
CC   -!- DOMAIN: The C2 domains mediate lipid and calcium binding. The N-
CC       terminal C2 domain binds calcium ions and is important for
CC       calcium-dependent lipid binding and interaction with membranes.
CC       Two calcium ions are bound at a high-affinity site and a third
CC       calcium ion is bound with lower affinity. May bind up to four
CC       calcium ions. In contrast, the second C2 domain apparently does
CC       not bind calcium (PubMed:24373768). The third C2 domain mediates
CC       interaction with membranes enriched in phosphatidylinositol 4,5-
CC       bisphosphate and is required for location at the cell membrane
CC       (PubMed:23791178). {ECO:0000269|PubMed:23791178,
CC       ECO:0000269|PubMed:24373768}.
CC   -!- DOMAIN: Contains a barrel-like domain that binds
CC       glycerophospholipids in its interior; can bind two lipid molecules
CC       simultaneously. Binds a variety of lipids, including
CC       phosphatidylethanolamine, phosphatidylcholine and
CC       phosphatidylinositol (PubMed:24847877).
CC       {ECO:0000269|PubMed:24847877}.
CC   -!- SIMILARITY: Belongs to the extended synaptotagmin family.
CC       {ECO:0000305}.
CC   -!- SIMILARITY: Contains 3 C2 domains. {ECO:0000255|PROSITE-
CC       ProRule:PRU00041}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA91539.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAC85769.1; Type=Frameshift; Positions=800; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; DQ993201; ABJ97706.1; -; mRNA.
DR   EMBL; AY368150; AAR89381.1; -; mRNA.
DR   EMBL; AK001181; BAA91539.1; ALT_INIT; mRNA.
DR   EMBL; AK124091; BAC85769.1; ALT_FRAME; mRNA.
DR   EMBL; AK126214; BAC86489.1; -; mRNA.
DR   EMBL; CH236954; EAL23931.1; -; Genomic_DNA.
DR   EMBL; AB033054; BAA86542.2; -; mRNA.
DR   EMBL; AL833233; CAH10642.1; -; mRNA.
DR   EMBL; BC013957; AAH13957.2; -; mRNA.
DR   EMBL; AJ303365; CAC33887.1; -; mRNA.
DR   CCDS; CCDS34791.1; -. [A0FGR8-2]
DR   RefSeq; NP_065779.1; NM_020728.2. [A0FGR8-2]
DR   UniGene; Hs.490795; -.
DR   PDB; 2DMG; NMR; -; A=785-913.
DR   PDB; 4NPJ; X-ray; 2.10 A; A/B=363-660.
DR   PDB; 4NPK; X-ray; 2.55 A; A=363-660.
DR   PDB; 4P42; X-ray; 2.44 A; A/B=191-662.
DR   PDBsum; 2DMG; -.
DR   PDBsum; 4NPJ; -.
DR   PDBsum; 4NPK; -.
DR   PDBsum; 4P42; -.
DR   ProteinModelPortal; A0FGR8; -.
DR   SMR; A0FGR8; 191-659, 756-919.
DR   BioGrid; 121556; 9.
DR   IntAct; A0FGR8; 8.
DR   MINT; MINT-4541681; -.
DR   STRING; 9606.ENSP00000251527; -.
DR   PhosphoSite; A0FGR8; -.
DR   BioMuta; ESYT2; -.
DR   MaxQB; A0FGR8; -.
DR   PaxDb; A0FGR8; -.
DR   PRIDE; A0FGR8; -.
DR   DNASU; 57488; -.
DR   Ensembl; ENST00000251527; ENSP00000251527; ENSG00000117868. [A0FGR8-2]
DR   GeneID; 57488; -.
DR   KEGG; hsa:57488; -.
DR   UCSC; uc003wob.1; human. [A0FGR8-2]
DR   UCSC; uc003woc.1; human. [A0FGR8-1]
DR   CTD; 57488; -.
DR   GeneCards; GC07M158523; -.
DR   H-InvDB; HIX0007266; -.
DR   HGNC; HGNC:22211; ESYT2.
DR   HPA; HPA002132; -.
DR   neXtProt; NX_A0FGR8; -.
DR   PharmGKB; PA165617947; -.
DR   eggNOG; COG5038; -.
DR   GeneTree; ENSGT00550000074417; -.
DR   HOVERGEN; HBG055795; -.
DR   InParanoid; A0FGR8; -.
DR   OrthoDB; EOG7RNJZK; -.
DR   PhylomeDB; A0FGR8; -.
DR   TreeFam; TF324255; -.
DR   ChiTaRS; ESYT2; human.
DR   EvolutionaryTrace; A0FGR8; -.
DR   GeneWiki; FAM62B; -.
DR   GenomeRNAi; 57488; -.
DR   NextBio; 63768; -.
DR   PRO; PR:A0FGR8; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; A0FGR8; -.
DR   CleanEx; HS_FAM62B; -.
DR   ExpressionAtlas; A0FGR8; baseline and differential.
DR   Genevisible; A0FGR8; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IBA:GO_Central.
DR   GO; GO:0031234; C:extrinsic component of cytoplasmic side of plasma membrane; IMP:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:FlyBase.
DR   GO; GO:0031227; C:intrinsic component of endoplasmic reticulum membrane; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0044232; C:organelle membrane contact site; IDA:UniProtKB.
DR   GO; GO:0005509; F:calcium ion binding; IDA:UniProtKB.
DR   GO; GO:0005544; F:calcium-dependent phospholipid binding; IDA:FlyBase.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0031210; F:phosphatidylcholine binding; IDA:UniProtKB.
DR   GO; GO:0008429; F:phosphatidylethanolamine binding; IDA:UniProtKB.
DR   GO; GO:0035091; F:phosphatidylinositol binding; IDA:UniProtKB.
DR   GO; GO:0006897; P:endocytosis; IEA:UniProtKB-KW.
DR   GO; GO:0006869; P:lipid transport; IEA:UniProtKB-KW.
DR   Gene3D; 2.60.40.150; -; 3.
DR   InterPro; IPR000008; C2_dom.
DR   Pfam; PF00168; C2; 3.
DR   SMART; SM00239; C2; 3.
DR   SUPFAM; SSF49562; SSF49562; 3.
DR   PROSITE; PS50004; C2; 3.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Calcium; Cell membrane;
KW   Complete proteome; Endocytosis; Endoplasmic reticulum;
KW   Lipid transport; Lipid-binding; Membrane; Metal-binding;
KW   Phosphoprotein; Polymorphism; Reference proteome; Repeat;
KW   Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    921       Extended synaptotagmin-2.
FT                                /FTId=PRO_0000278258.
FT   TOPO_DOM      1    103       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    104    124       Helical. {ECO:0000255}.
FT   TOPO_DOM    125    127       Lumenal. {ECO:0000255}.
FT   TRANSMEM    128    148       Helical. {ECO:0000255}.
FT   TOPO_DOM    149    921       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      372    473       C2 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00041}.
FT   DOMAIN      523    617       C2 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00041}.
FT   DOMAIN      788    892       C2 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00041}.
FT   REGION      195    370       Glycerophospholipid-binding barrel-like
FT                                domain.
FT   REGION      833    840       Required for phosphatidylinositol 4,5-
FT                                bisphosphate-dependent location at the
FT                                cell membrane.
FT   COMPBIAS    736    739       Poly-Ser.
FT   METAL       400    400       Calcium 1; via carbonyl oxygen.
FT                                {ECO:0000269|PubMed:24373768}.
FT   METAL       401    401       Calcium 1. {ECO:0000269|PubMed:24373768}.
FT   METAL       401    401       Calcium 2. {ECO:0000269|PubMed:24373768}.
FT   METAL       413    413       Calcium 2. {ECO:0000269|PubMed:24373768}.
FT   METAL       460    460       Calcium 1. {ECO:0000269|PubMed:24373768}.
FT   METAL       460    460       Calcium 2. {ECO:0000269|PubMed:24373768}.
FT   METAL       461    461       Calcium 2; via carbonyl oxygen.
FT                                {ECO:0000269|PubMed:24373768}.
FT   METAL       462    462       Calcium 1. {ECO:0000269|PubMed:24373768}.
FT   METAL       462    462       Calcium 2. {ECO:0000269|PubMed:24373768}.
FT   METAL       462    462       Calcium 3; via carbonyl oxygen.
FT                                {ECO:0000269|PubMed:24373768}.
FT   METAL       464    464       Calcium 3; via carbonyl oxygen.
FT                                {ECO:0000269|PubMed:24373768}.
FT   METAL       466    466       Calcium 3. {ECO:0000269|PubMed:24373768}.
FT   METAL       467    467       Calcium 1. {ECO:0000269|PubMed:24373768}.
FT   MOD_RES     691    691       Phosphoserine.
FT                                {ECO:0000269|PubMed:19690332}.
FT   MOD_RES     693    693       Phosphoserine.
FT                                {ECO:0000269|PubMed:24275569}.
FT   MOD_RES     705    705       Phosphothreonine.
FT                                {ECO:0000269|PubMed:24275569}.
FT   MOD_RES     738    738       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q3TZZ7}.
FT   MOD_RES     739    739       Phosphoserine.
FT                                {ECO:0000269|PubMed:19690332}.
FT   MOD_RES     743    743       Phosphoserine.
FT                                {ECO:0000269|PubMed:17924679,
FT                                ECO:0000269|PubMed:18669648,
FT                                ECO:0000269|PubMed:18691976,
FT                                ECO:0000269|PubMed:20068231}.
FT   MOD_RES     748    748       Phosphoserine.
FT                                {ECO:0000269|PubMed:19690332}.
FT   MOD_RES     755    755       Phosphoserine.
FT                                {ECO:0000269|PubMed:18669648,
FT                                ECO:0000269|PubMed:19690332}.
FT   MOD_RES     758    758       Phosphoserine.
FT                                {ECO:0000269|PubMed:18669648,
FT                                ECO:0000269|PubMed:18691976,
FT                                ECO:0000269|PubMed:19690332,
FT                                ECO:0000269|PubMed:20068231,
FT                                ECO:0000269|PubMed:21406692}.
FT   MOD_RES     761    761       Phosphoserine.
FT                                {ECO:0000269|PubMed:18669648,
FT                                ECO:0000269|PubMed:18691976,
FT                                ECO:0000269|PubMed:19690332,
FT                                ECO:0000269|PubMed:20068231,
FT                                ECO:0000269|PubMed:21406692,
FT                                ECO:0000269|PubMed:24275569}.
FT   VAR_SEQ       1    593       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_023236.
FT   VAR_SEQ       1    204       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_023238.
FT   VAR_SEQ       1     97       MTANRDAALSSHRHPGCAQRPRTPTFASSSQRRSAFGFDDG
FT                                NFPGLGERSHAPGSRLGARRRAKTARGLRGHRQRGAGAGLS
FT                                RPGSARAPSPPRPGG -> MTPPSRAEAGVRRSRVPSEGRW
FT                                RGAEPPGISASTQPASAGRAARHCGAMSGARGEGPEAGAGG
FT                                AGGRAA (in isoform 2).
FT                                {ECO:0000303|Ref.2}.
FT                                /FTId=VSP_023239.
FT   VAR_SEQ     550    550       S -> SNPLEFNPDVLKKTAVQRALKS (in isoform
FT                                6). {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_038324.
FT   VAR_SEQ     594    603       NPKRQDLEVE -> MPVLPPCVLQ (in isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_023240.
FT   VAR_SEQ     706    731       PVIGGSDKPGMEEKAQPPEAGPQGLH -> SQSRSRPPASP
FT                                RTSRCPSPPRSCGKG (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_023241.
FT   VAR_SEQ     732    921       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_023242.
FT   VARIANT     210    210       C -> S (in dbSNP:rs13233513).
FT                                /FTId=VAR_030725.
FT   VARIANT     638    638       S -> G (in dbSNP:rs2305473).
FT                                {ECO:0000269|PubMed:14702039}.
FT                                /FTId=VAR_030726.
FT   MUTAGEN     401    401       D->A: Abolishes calcium binding; when
FT                                associated with A-413.
FT                                {ECO:0000269|PubMed:24373768}.
FT   MUTAGEN     413    413       D->A: Abolishes calcium binding; when
FT                                associated with A-401.
FT                                {ECO:0000269|PubMed:24373768}.
FT   MUTAGEN     413    413       D->N: Strongly reduces calcium binding.
FT                                {ECO:0000269|PubMed:24373768}.
FT   MUTAGEN     466    466       D->A: Impairs binding of the third
FT                                calcium ion, but has no effect on the
FT                                binding of the other two calcium ions.
FT                                {ECO:0000269|PubMed:24373768}.
FT   MUTAGEN     833    840       KRRSGRRK->AAASGAAA: Abolishes location at
FT                                the cell membrane.
FT                                {ECO:0000269|PubMed:23791178}.
FT   CONFLICT    141    141       L -> V (in Ref. 7; CAH10642).
FT                                {ECO:0000305}.
FT   CONFLICT    612    612       S -> P (in Ref. 3; BAC85769).
FT                                {ECO:0000305}.
FT   CONFLICT    615    615       N -> S (in Ref. 3; BAC86489).
FT                                {ECO:0000305}.
FT   CONFLICT    795    795       R -> Q (in Ref. 3; BAC85769).
FT                                {ECO:0000305}.
FT   HELIX       196    219       {ECO:0000244|PDB:4P42}.
FT   HELIX       221    226       {ECO:0000244|PDB:4P42}.
FT   HELIX       230    232       {ECO:0000244|PDB:4P42}.
FT   STRAND      235    241       {ECO:0000244|PDB:4P42}.
FT   STRAND      248    255       {ECO:0000244|PDB:4P42}.
FT   STRAND      264    282       {ECO:0000244|PDB:4P42}.
FT   TURN        283    286       {ECO:0000244|PDB:4P42}.
FT   STRAND      287    304       {ECO:0000244|PDB:4P42}.
FT   STRAND      316    323       {ECO:0000244|PDB:4P42}.
FT   STRAND      326    333       {ECO:0000244|PDB:4P42}.
FT   HELIX       334    337       {ECO:0000244|PDB:4P42}.
FT   TURN        341    345       {ECO:0000244|PDB:4P42}.
FT   HELIX       348    358       {ECO:0000244|PDB:4P42}.
FT   STRAND      365    370       {ECO:0000244|PDB:4P42}.
FT   HELIX       372    379       {ECO:0000244|PDB:4P42}.
FT   STRAND      384    396       {ECO:0000244|PDB:4NPJ}.
FT   TURN        405    407       {ECO:0000244|PDB:4P42}.
FT   STRAND      414    420       {ECO:0000244|PDB:4NPJ}.
FT   STRAND      423    426       {ECO:0000244|PDB:4NPJ}.
FT   STRAND      437    446       {ECO:0000244|PDB:4NPJ}.
FT   STRAND      453    460       {ECO:0000244|PDB:4NPJ}.
FT   STRAND      463    465       {ECO:0000244|PDB:4NPJ}.
FT   STRAND      467    475       {ECO:0000244|PDB:4NPJ}.
FT   HELIX       476    482       {ECO:0000244|PDB:4NPJ}.
FT   STRAND      483    490       {ECO:0000244|PDB:4NPJ}.
FT   STRAND      494    496       {ECO:0000244|PDB:4NPJ}.
FT   STRAND      498    512       {ECO:0000244|PDB:4NPJ}.
FT   HELIX       515    524       {ECO:0000244|PDB:4NPJ}.
FT   STRAND      535    547       {ECO:0000244|PDB:4NPJ}.
FT   STRAND      552    554       {ECO:0000244|PDB:4P42}.
FT   STRAND      560    566       {ECO:0000244|PDB:4NPJ}.
FT   STRAND      569    572       {ECO:0000244|PDB:4NPJ}.
FT   STRAND      583    593       {ECO:0000244|PDB:4NPJ}.
FT   TURN        595    597       {ECO:0000244|PDB:4NPJ}.
FT   STRAND      599    606       {ECO:0000244|PDB:4NPJ}.
FT   TURN        607    609       {ECO:0000244|PDB:4NPJ}.
FT   STRAND      612    619       {ECO:0000244|PDB:4NPJ}.
FT   HELIX       621    624       {ECO:0000244|PDB:4NPJ}.
FT   HELIX       627    629       {ECO:0000244|PDB:4NPJ}.
FT   STRAND      630    636       {ECO:0000244|PDB:4NPJ}.
FT   STRAND      638    640       {ECO:0000244|PDB:4NPJ}.
FT   STRAND      645    656       {ECO:0000244|PDB:4NPJ}.
FT   STRAND      789    797       {ECO:0000244|PDB:2DMG}.
FT   TURN        798    801       {ECO:0000244|PDB:2DMG}.
FT   STRAND      802    811       {ECO:0000244|PDB:2DMG}.
FT   STRAND      823    831       {ECO:0000244|PDB:2DMG}.
FT   STRAND      835    837       {ECO:0000244|PDB:2DMG}.
FT   STRAND      851    858       {ECO:0000244|PDB:2DMG}.
FT   HELIX       862    867       {ECO:0000244|PDB:2DMG}.
FT   STRAND      869    876       {ECO:0000244|PDB:2DMG}.
FT   STRAND      889    894       {ECO:0000244|PDB:2DMG}.
FT   TURN        899    902       {ECO:0000244|PDB:2DMG}.
SQ   SEQUENCE   921 AA;  102357 MW;  D57F1BD9BB0A0C8A CRC64;
     MTANRDAALS SHRHPGCAQR PRTPTFASSS QRRSAFGFDD GNFPGLGERS HAPGSRLGAR
     RRAKTARGLR GHRQRGAGAG LSRPGSARAP SPPRPGGPEN PGGVLSVELP GLLAQLARSF
     ALLLPVYALG YLGLSFSWVL LALALLAWCR RSRGLKALRL CRALALLEDE ERVVRLGVRA
     CDLPAWVHFP DTERAEWLNK TVKHMWPFIC QFIEKLFRET IEPAVRGANT HLSTFSFTKV
     DVGQQPLRIN GVKVYTENVD KRQIILDLQI SFVGNCEIDL EIKRYFCRAG VKSIQIHGTM
     RVILEPLIGD MPLVGALSIF FLRKPLLEIN WTGLTNLLDV PGLNGLSDTI ILDIISNYLV
     LPNRITVPLV SEVQIAQLRF PVPKGVLRIH FIEAQDLQGK DTYLKGLVKG KSDPYGIIRV
     GNQIFQSRVI KENLSPKWNE VYEALVYEHP GQELEIELFD EDPDKDDFLG SLMIDLIEVE
     KERLLDEWFT LDEVPKGKLH LRLEWLTLMP NASNLDKVLT DIKADKDQAN DGLSSALLIL
     YLDSARNLPS GKKISSNPNP VVQMSVGHKA QESKIRYKTN EPVWEENFTF FIHNPKRQDL
     EVEVRDEQHQ CSLGNLKVPL SQLLTSEDMT VSQRFQLSNS GPNSTIKMKI ALRVLHLEKR
     ERPPDHQHSA QVKRPSVSKE GRKTSIKSHM SGSPGPGGSN TAPSTPVIGG SDKPGMEEKA
     QPPEAGPQGL HDLGRSSSSL LASPGHISVK EPTPSIASDI SLPIATQELR QRLRQLENGT
     TLGQSPLGQI QLTIRHSSQR NKLIVVVHAC RNLIAFSEDG SDPYVRMYLL PDKRRSGRRK
     THVSKKTLNP VFDQSFDFSV SLPEVQRRTL DVAVKNSGGF LSKDKGLLGK VLVALASEEL
     AKGWTQWYDL TEDGTRPQAM T
//
